Skip to main content
Top
Published in: BMC Cancer 1/2015

Open Access 01-12-2015 | Research article

Gangliocytic paraganglioma: a multi-institutional retrospective study in Japan

Authors: Yoichiro Okubo, Tetsuo Nemoto, Megumi Wakayama, Naobumi Tochigi, Minoru Shinozaki, Takao Ishiwatari, Kyoko Aki, Masaru Tsuchiya, Hajime Aoyama, Kanade Katsura, Takeshi Fujii, Takashi Nishigami, Tomoyuki Yokose, Yasuo Ohkura, Kazutoshi Shibuya

Published in: BMC Cancer | Issue 1/2015

Login to get access

Abstract

Background

Gangliocytic paraganglioma (GP) is an extremely rare benign tumor that commonly arises from the second part of the duodenum. Since GP exhibit neither prominent mitotic activity nor Ki-67 immunoreactivity, this tumor is often misdiagnosed as neuroendocrine tumor (NET) G1 (carcinoid tumor). However, patients with GP may have a better prognosis than patients with NET G1. This fact emphasizes the importance of differentiating GP from NET G1, but few studies have reported the epidemiology and histopathology of GP because of its rarity. To differentiate GP from NET G1 with ease, we conducted a multi-institutional retrospective study analyzing the morphometric and immunohistochemical features of this tumor.

Methods

Since only a limited number of patients with GP could be identified in our institute, we conducted a multi-institutional retrospective study of GP in Japan, which was approved by the Ethics Committee of our medical institute. The obtained tissue sections underwent detailed morphometric and immunohistochemical analyses. Additionally, to differentiate GP from NET G1 with ease, immunohistochemical findings were compared.

Results

In our examination of 12 cases of duodenal GP, we found that epithelioid cells of GP exhibited positive reactivity for progesterone receptor and pancreatic polypeptide, whereas tumor cells of NET G1 were completely negative reactivity for both. Additionally, although GP is considered to be an extremely rare NET, we found that four (40.0%) of the ten patients at our institute with duodenal NET G1 actually had GP.

Conclusions

Although GP is regarded as a rare NET, our results suggest that it accounts for a substantial percentage of duodenal NETs. Additionally, confirmation of immunoreactivity for progesterone receptor and pancreatic polypeptide can assist in differentiating GP from NET G1.
Literature
1.
go back to reference Okubo Y, Yokose T, Tuchiya M, Mituda A, Wakayama M, Hasegawa C, et al. Duodenal gangliocytic paraganglioma showing lymph node metastasis: a rare case report. Diagn Pathol. 2010;5:27.CrossRefPubMedPubMedCentral Okubo Y, Yokose T, Tuchiya M, Mituda A, Wakayama M, Hasegawa C, et al. Duodenal gangliocytic paraganglioma showing lymph node metastasis: a rare case report. Diagn Pathol. 2010;5:27.CrossRefPubMedPubMedCentral
2.
go back to reference Dahl EV, Waugh JM, Dahlin DC. Gastrointestinal ganglioneuromas; brief review with report of a duodenal ganglioneuroma. Am J Pathol. 1957;33:953–65.PubMedPubMedCentral Dahl EV, Waugh JM, Dahlin DC. Gastrointestinal ganglioneuromas; brief review with report of a duodenal ganglioneuroma. Am J Pathol. 1957;33:953–65.PubMedPubMedCentral
3.
go back to reference Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264–9.CrossRefPubMed Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264–9.CrossRefPubMed
4.
go back to reference Okubo Y, Wakayama M, Nemoto T, Kitahara K, Nakayama H, Shibuya K, et al. Literature survey on epidemiology and pathology of gangliocytic paraganglioma. BMC Cancer. 2011;11:187.CrossRefPubMedPubMedCentral Okubo Y, Wakayama M, Nemoto T, Kitahara K, Nakayama H, Shibuya K, et al. Literature survey on epidemiology and pathology of gangliocytic paraganglioma. BMC Cancer. 2011;11:187.CrossRefPubMedPubMedCentral
5.
go back to reference Oberg K, Castellano D. Current knowledge on diagnosis and staging of neuroendocrine tumors. Cancer Metastasis Rev. 2011;30 Suppl 1:3–7.CrossRefPubMed Oberg K, Castellano D. Current knowledge on diagnosis and staging of neuroendocrine tumors. Cancer Metastasis Rev. 2011;30 Suppl 1:3–7.CrossRefPubMed
6.
go back to reference Oberg KE. Gastrointestinal neuroendocrine tumors. Ann Oncol. 2010;21 Suppl 7:vii72–80.PubMed Oberg KE. Gastrointestinal neuroendocrine tumors. Ann Oncol. 2010;21 Suppl 7:vii72–80.PubMed
7.
go back to reference Pape UF, Jann H, Muller-Nordhorn J, Bockelbrink A, Berndt U, Willich SN, et al. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer. 2008;113:256–65.CrossRefPubMed Pape UF, Jann H, Muller-Nordhorn J, Bockelbrink A, Berndt U, Willich SN, et al. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer. 2008;113:256–65.CrossRefPubMed
8.
go back to reference Li B, Li Y, Tian XY, Luo BN, Li Z. Malignant gangliocytic paraganglioma of the duodenum with distant metastases and a lethal course. World J Gastroenterol. 2014;20:15454–61.CrossRefPubMedPubMedCentral Li B, Li Y, Tian XY, Luo BN, Li Z. Malignant gangliocytic paraganglioma of the duodenum with distant metastases and a lethal course. World J Gastroenterol. 2014;20:15454–61.CrossRefPubMedPubMedCentral
9.
go back to reference Witkiewicz A, Galler A, Yeo CJ, Gross SD. Gangliocytic paraganglioma: case report and review of the literature. J Gastrointest Surg. 2007;11:1351–4.CrossRefPubMed Witkiewicz A, Galler A, Yeo CJ, Gross SD. Gangliocytic paraganglioma: case report and review of the literature. J Gastrointest Surg. 2007;11:1351–4.CrossRefPubMed
10.
go back to reference Lin D, Hu Y, Xing X, Ding L, Liu H, Li Y, et al. Pulmonary gangliocytic paraganglioma: a case report and review of the literature. Int J Clin Exp Pathol. 2014;7:432–7.PubMed Lin D, Hu Y, Xing X, Ding L, Liu H, Li Y, et al. Pulmonary gangliocytic paraganglioma: a case report and review of the literature. Int J Clin Exp Pathol. 2014;7:432–7.PubMed
11.
go back to reference Kloppel GAR, Capella C, Klimstra DS, Albores-Saavedra J, Solcia E, Rindi G, et al. Neruoendocrine neoplasms of the ampullary region. Lyon: IARC press; 2010. Kloppel GAR, Capella C, Klimstra DS, Albores-Saavedra J, Solcia E, Rindi G, et al. Neruoendocrine neoplasms of the ampullary region. Lyon: IARC press; 2010.
12.
go back to reference Park SJ, Kim Do H, Lim H, Lee JH, Choi KD, Song HJ, et al. Endoscopic resection as a possible radical treatment for duodenal gangliocytic paraganglioma: a report of four cases. Korean J Gastroenterol. 2014;63:114–9.CrossRefPubMed Park SJ, Kim Do H, Lim H, Lee JH, Choi KD, Song HJ, et al. Endoscopic resection as a possible radical treatment for duodenal gangliocytic paraganglioma: a report of four cases. Korean J Gastroenterol. 2014;63:114–9.CrossRefPubMed
13.
go back to reference Perrone T, Sibley RK, Rosai J. Duodenal gangliocytic paraganglioma. An immunohistochemical and ultrastructural study and a hypothesis concerning its origin. Am J Surg Pathol. 1985;9:31–41.CrossRefPubMed Perrone T, Sibley RK, Rosai J. Duodenal gangliocytic paraganglioma. An immunohistochemical and ultrastructural study and a hypothesis concerning its origin. Am J Surg Pathol. 1985;9:31–41.CrossRefPubMed
14.
go back to reference Abdelbaqi MQ, Tahmasbi M, Ghayouri M. Gangliocytic paraganglioma of the appendix with features suggestive of malignancy, a rare case report and review of the literature. Int J Clin Exp Pathol. 2013;6:1948–52.PubMedPubMedCentral Abdelbaqi MQ, Tahmasbi M, Ghayouri M. Gangliocytic paraganglioma of the appendix with features suggestive of malignancy, a rare case report and review of the literature. Int J Clin Exp Pathol. 2013;6:1948–52.PubMedPubMedCentral
15.
go back to reference Ohtsuki Y, Watanabe R, Kimura M, Okamoto T, Murakami S, Mizukami Y, et al. Immunohistochemical and electron microscopic studies of a case of duodenal gangliocytic paraganglioma. Med Mol Morphol. 2009;42:245–9.CrossRefPubMed Ohtsuki Y, Watanabe R, Kimura M, Okamoto T, Murakami S, Mizukami Y, et al. Immunohistochemical and electron microscopic studies of a case of duodenal gangliocytic paraganglioma. Med Mol Morphol. 2009;42:245–9.CrossRefPubMed
16.
go back to reference Saito J, Hirata N, Furuzono M, Nakaji S, Inase M, Nagano H, et al. [A case of duodenal gangliocytic paraganglioma with lymph node metastasis]. Nihon Shokakibyo Gakkai Zasshi. 2010;107:639–48.PubMed Saito J, Hirata N, Furuzono M, Nakaji S, Inase M, Nagano H, et al. [A case of duodenal gangliocytic paraganglioma with lymph node metastasis]. Nihon Shokakibyo Gakkai Zasshi. 2010;107:639–48.PubMed
17.
go back to reference Guarda LA, Ordonez NG, del Junco GW, Luna MA. Gangliocytic paraganglioma of the duodenum: an immunocytochemical study. Am J Gastroenterol. 1983;78:794–8.PubMed Guarda LA, Ordonez NG, del Junco GW, Luna MA. Gangliocytic paraganglioma of the duodenum: an immunocytochemical study. Am J Gastroenterol. 1983;78:794–8.PubMed
18.
go back to reference Papathomas TG, de Krijger RR, Tischler AS. Paragangliomas: update on differential diagnostic considerations, composite tumors, and recent genetic developments. Semin Diagn Pathol. 2013;30:207–23.CrossRefPubMed Papathomas TG, de Krijger RR, Tischler AS. Paragangliomas: update on differential diagnostic considerations, composite tumors, and recent genetic developments. Semin Diagn Pathol. 2013;30:207–23.CrossRefPubMed
19.
go back to reference Amin SM, Albrechtsen NW, Forster J, Damjanov I. Gangliocytic paraganglioma of duodenum metastatic to lymph nodes and liver and extending into the retropancreatic space. Pathologica. 2013;105:90–3.PubMed Amin SM, Albrechtsen NW, Forster J, Damjanov I. Gangliocytic paraganglioma of duodenum metastatic to lymph nodes and liver and extending into the retropancreatic space. Pathologica. 2013;105:90–3.PubMed
20.
go back to reference Hruban RHPM, Klimstra DS. Tumors of the Pancreas, ENDOCRINE NEOPLASMS, Fascicle 6, 4th Series. Washington, DC: Armed Forces Institutes of Pathology; 2007. p. 286–7. Hruban RHPM, Klimstra DS. Tumors of the Pancreas, ENDOCRINE NEOPLASMS, Fascicle 6, 4th Series. Washington, DC: Armed Forces Institutes of Pathology; 2007. p. 286–7.
21.
go back to reference Tomic S, Warner T. Pancreatic somatostatin-secreting gangliocytic paraganglioma with lymph node metastases. Am J Gastroenterol. 1996;91:607–8.PubMed Tomic S, Warner T. Pancreatic somatostatin-secreting gangliocytic paraganglioma with lymph node metastases. Am J Gastroenterol. 1996;91:607–8.PubMed
22.
go back to reference Kawaguchi K, Takizawa T, Koike M, Tabata I, Goseki N. Multiple paraganglioneuromas. Virchows Arch A Pathol Anat Histopathol. 1985;406:373–80.CrossRefPubMed Kawaguchi K, Takizawa T, Koike M, Tabata I, Goseki N. Multiple paraganglioneuromas. Virchows Arch A Pathol Anat Histopathol. 1985;406:373–80.CrossRefPubMed
23.
go back to reference Lubensky IA, Pack S, Ault D, Vortmeyer AO, Libutti SK, Choyke PL, et al. Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis. Am J Pathol. 1998;153:223–31.CrossRefPubMedPubMedCentral Lubensky IA, Pack S, Ault D, Vortmeyer AO, Libutti SK, Choyke PL, et al. Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis. Am J Pathol. 1998;153:223–31.CrossRefPubMedPubMedCentral
24.
go back to reference Tomita T, Kimmel JR, Friesen SR, Doull V, Pollock HG. Pancreatic polypeptide in islet cell tumors. Morphologic and functional correlations. Cancer. 1985;56:1649–57.CrossRefPubMed Tomita T, Kimmel JR, Friesen SR, Doull V, Pollock HG. Pancreatic polypeptide in islet cell tumors. Morphologic and functional correlations. Cancer. 1985;56:1649–57.CrossRefPubMed
Metadata
Title
Gangliocytic paraganglioma: a multi-institutional retrospective study in Japan
Authors
Yoichiro Okubo
Tetsuo Nemoto
Megumi Wakayama
Naobumi Tochigi
Minoru Shinozaki
Takao Ishiwatari
Kyoko Aki
Masaru Tsuchiya
Hajime Aoyama
Kanade Katsura
Takeshi Fujii
Takashi Nishigami
Tomoyuki Yokose
Yasuo Ohkura
Kazutoshi Shibuya
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2015
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-015-1308-8

Other articles of this Issue 1/2015

BMC Cancer 1/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine